GEN Exclusives

More »

GEN News Highlights

More »
Dec 4, 2007

Skystar Establishes R&D Center in Shanghai

  • Skystar Bio-Pharmaceutical reported the opening of an R&D center in Shanghai registered as Shanghai Siqiang Biotechnology.

    The new 200-square-meter center utilizes equipment such as liquid chromatography and infrared dissolution. Lingmei Jin, will be one of six key researchers.

    “Our new R&D Center further strengthens our capabilities with experienced and distinguished professionals in each of our three key product areas,” remarks Skystar's CEO, Weibing Lu. “We look forward to working with Ms. Jin and the rest of our new research team to develop vaccines for common diseases among humans and animals, medicines for parasitic diseases, and microorganism products that include probiotics and antibiotics.

    “By locating our R&D center in Shanghai, the economic center of China,” Lu adds, “we believe the facility will attract high-level talent from all over the country and serve as a base to cultivate future talent.”


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

The Triple Package and Success

One theory for explaining “success," put forward by Amy Chua Jed Rubenfeld, posits cultural traits such as a superiority complex, personal insecurity and impulse control. Union College professors Joshua Hart and Christopher Chabris counter that intelligence, conscientiousness, and economic advantage are the most likely elements of success, regardless of ethnicity. Do you think that Hart-Chabris make a better argument for achieving success than the Chua-Rubenfeld theory?

More »